- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 105.89M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $48M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $48M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $192M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $226M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.03B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.02B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.16B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.15B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $150M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $185M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 86.2M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $4M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $707M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $462M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.05 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $32M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $109M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$4M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$16M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $10M |